12-109561103-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM1PP3PP5
The NM_052845.4(MMAB):c.521C>T(p.Ser174Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000329 in 1,609,622 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S174S) has been classified as Likely benign.
Frequency
Consequence
NM_052845.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- methylmalonic aciduria, cblB typeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 151920Hom.: 0 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.0000644 AC: 16AN: 248484 AF XY: 0.0000742 show subpopulations
GnomAD4 exome AF: 0.0000295 AC: 43AN: 1457702Hom.: 0 Cov.: 35 AF XY: 0.0000358 AC XY: 26AN XY: 725408 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000658 AC: 10AN: 151920Hom.: 0 Cov.: 30 AF XY: 0.0000674 AC XY: 5AN XY: 74176 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Methylmalonic aciduria, cblB type Pathogenic:4Uncertain:2
- -
- -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
- -
This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 174 of the MMAB protein (p.Ser174Leu). This variant is present in population databases (rs140881518, gnomAD 0.04%). This missense change has been observed in individual(s) with MMAB-related conditions (PMID: 16410054, 23707710, 34796408; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 445684). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
- -
MMAB-related disorder Pathogenic:1
The MMAB c.521C>T variant is predicted to result in the amino acid substitution p.Ser174Leu. This variant was reported in the homozygous state in two individuals with methylmalonic aciduria (MMA), cblB type; at least one of the reported patients had the diagnosis of cblB type MMA confirmed by cellular complementation studies (Lerner-Ellis et al. 2006. PubMed ID: 16410054; Forny et al 2021. PubMed ID: 34796408). This variant was also reported in the heterozygous state without a second variant identified in a patient with undiagnosed MMA (Illson et al. 2013. PubMed ID: 23707710). This variant is reported in 0.036% of alleles in individuals of South Asian descent in gnomAD. This variant is interpreted as likely pathogenic. -
not provided Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at